Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): A randomised, parallel-group trial

The Lancet

Volumn 377, Issue 9762, 2011, Pages 312-320

  Brown, Morris J ^a,b   McInnes, Gordon T ^b,c   Papst, Cheraz Cherif ^d   Zhang, Jack ^d   MacDonald, Thomas M ^b,e  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b British Cardiovascular Society   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d NOVARTIS PHARMA AG   (Switzerland)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; AMLODIPINE; HYDROCHLOROTHIAZIDE; PLACEBO;

ADD ON THERAPY; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; BLOOD PRESSURE REGULATION; COLITIS; COMBINATION CHEMOTHERAPY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; ESSENTIAL HYPERTENSION; FEMALE; HEART FAILURE; HUMAN; HYPERTENSIVE CRISIS; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; ORTHOSTATIC HYPOTENSION; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIGMOIDITIS; SYSTOLIC BLOOD PRESSURE;

EID: 78751646571     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)62003-X     Document Type: Article

References (29)

1. P Primatesta, NR Poulter Improvement in hypertension management in England: results from the Health Survey for England 2003 J Hypertens 24 2006 1193 1200
2. AV Chobanian, GL Bakris, HR Black The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572
3. G Mancia, G De Backer, A Dominiczak 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J 28 2007 1462 1536
4. S Julius, SE Kjeldsen, M Weber Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial Lancet 363 2004 2022 2031
5. F Turnbull Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials Lancet 362 2003 1527 1535
6. B Dahlof, PS Sever, NR Poulter Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial Lancet 366 2005 895 906
7. DS Wald, M Law, JK Morris, JP Bestwick, NJ Wald Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials Am J Med 122 2009 290 300
8. RC Braun-Dullaeus, J Zhang, S Hristoskova, DA Haring, W Liao First-line therapy with aliskiren/amlodipine combination provides robust blood pressure reductions in patients with moderate to severe hypertension J Clin Hypertens 12 suppl 1 2010 A27
9. MJ Brown Aliskiren Circulation 118 2008 773 784
10. MJ Brown Renin: friend or foe? Heart 93 2007 1026 1033
11. DH Zappe, BF Palmer, DA Calhoun, D Purkayastha, R Samuel, KA Jamerson Effectiveness of initiating treatment with valsartan/hydrochlorothiazide in patients with stage-1 or stage-2 hypertension J Hum Hypertens 24 2010 483 491
12. RD Feldman, GY Zou, MK Vandervoort, CJ Wong, SA Nelson, BG Feagan A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial Hypertension 53 2009 646 653
13. T Philipp, TR Smith, R Glazer Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension Clin Ther 29 2007 563 580
14. SG Chrysant, M Melino, S Karki, J Lee, R Heyrman The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study Clin Ther 30 2008 587 604
15. NICE Hypertension: management of hypertension in adults in primary care (NICE clinical guideline 34) 2006 National Institute for Health and Clinical Excellence London http://www.nice.org.uk/nicemedia/live/10986/30114/30114.pdf (accessed Oct 26, 2010).
16. B Dahlöf, RB Devereux, SE Kjeldsen Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 2002 995 1003 (Pubitemid 34286536)
17. K Jamerson, MA Weber, GL Bakris Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients N Engl J Med 359 2008 2417 2428
18. R Fogari, G Malamani, A Zoppi Effect on the development of ankle edema of adding delapril to manidipine in patients with mild to moderate essential hypertension: a three-way crossover study Clin Ther 29 2007 413 418
19. FH Messerli, S Oparil, Z Feng Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension Am J Cardiol 86 2000 1182 1187
20. R Fogari, A Zoppi, G Derosa Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients J Hum Hypertens 21 2007 220 224
21. S Lewington, R Clarke, N Qizilbash, R Peto, R Collins Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 2002 1903 1913
22. C Newton-Cheh, T Johnson, V Gateva Genome-wide association study identifies eight loci associated with blood pressure Nat Genet 41 2009 666 676
23. GL Bakris, MR Weir Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches J Clin Hypertens (Greenwich) 5 2003 202 209
24. MR Law, JK Morris, NJ Wald Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies BMJ 338 2009 b1665
25. JH Laragh, RL Letcher, TG Pickering Renin profiling for diagnosis and treatment of hypertension JAMA 241 1979 151 156
26. MJ Brown Heterogeneity of blood pressure response to therapy Am J Hypertens 23 2010 926 928
27. SJ Hood, KP Taylor, MJ Ashby, MJ Brown The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio Circulation 116 2007 268 275
28. NM Kaplan, DC Kem, OB Holland, NJ Kramer, J Higgins, C Gomez-Sanchez The intravenous furosemide test: a simple way to evaluate renin responsiveness Ann Intern Med 84 1976 639 645
29. MJ Brown, JE Dickerson Alpha-blockade and calcium antagonism: an effective and well-tolerated combination for the treatment of resistant hypertension J Hypertens 13 1995 701 707